glp-1 drugs moa Recent updates on agonists: Current advancements & challenges Mechanism of action of GLP-1

Patell, who also serves as chair of NBCAs Council on Emerging Researchers in Thrombosis, found that people taking GLP-1 drugs were 48% less likely to develop deep vein thrombosis or pulmonary embolism compared to those not on these medications

Still, the findings suggest the need for patient-tailored decisions to maximize the benefits and minimize harms and overuse of treatments, they concluded.

Studies have shown that routine preoperative gastric ultrasound can help tailor perioperative management by identifying patients at high or low risk of aspiration, thereby potentially improving patient safety [11,12]

10.1080/07853890.2017.1306653 24 KapadiaP.BikkinaP.LandichoM

JAMA 2018

Food and Drug Administration, 2008 [Google Scholar] 27.Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O